ZOLGENSMA ITCAL Trademark
Trademark Overview
On Thursday, January 18, 2024, a trademark application was filed for ZOLGENSMA ITCAL with the United States Patent and Trademark Office. The USPTO has given the ZOLGENSMA ITCAL trademark a serial number of 79391775. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, March 12, 2025. This trademark is owned by NOVARTIS AG. The ZOLGENSMA ITCAL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
General Information
| Serial Number | 79391775 |
| Word Mark | ZOLGENSMA ITCAL |
| Filing Date | Thursday, January 18, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, March 12, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 22, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOVARTIS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Thursday, March 21, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 26, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, April 8, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 8, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, April 8, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, April 8, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Monday, April 8, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, April 8, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, August 9, 2024 | ASSIGNED TO EXAMINER |
| Monday, December 16, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 17, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, March 12, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, January 3, 2025 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Wednesday, March 5, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, March 6, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, March 12, 2025 | REFUSAL PROCESSED BY MPU |
| Saturday, March 29, 2025 | REFUSAL PROCESSED BY IB |
